Cargando…

Association of prostate volume with incidence and aggressiveness of prostate cancer

OBJECTIVE: The aim of this study was to investigate the possible correlation between prostate volume and aggressiveness and incidence of prostate cancer (PCa). PATIENTS AND METHODS: A chart review of a cohort of 448 consecutive prostate biopsy-naive men was performed. These men underwent at least a...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Khalil, Shadi, Ibilibor, Christine, Cammack, James Thomas, de Riese, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087757/
https://www.ncbi.nlm.nih.gov/pubmed/27822463
http://dx.doi.org/10.2147/RRU.S117963
_version_ 1782463965703438336
author Al-Khalil, Shadi
Ibilibor, Christine
Cammack, James Thomas
de Riese, Werner
author_facet Al-Khalil, Shadi
Ibilibor, Christine
Cammack, James Thomas
de Riese, Werner
author_sort Al-Khalil, Shadi
collection PubMed
description OBJECTIVE: The aim of this study was to investigate the possible correlation between prostate volume and aggressiveness and incidence of prostate cancer (PCa). PATIENTS AND METHODS: A chart review of a cohort of 448 consecutive prostate biopsy-naive men was performed. These men underwent at least a 12-core biopsy at our institution due to increased prostate-specific antigen serum levels (>4 ng/mL) and/or suspicious findings on digital rectal examination during the period between 2008 and 2013. Transrectal ultrasound was used to determine the prostate volume. RESULTS: The positive biopsy rate was 66% for patients with a prostate volume of ≤35 cc and 40% for patients with a prostate volume of ≥65 cc (P<0.001). Of the 110 patients testing positive on biopsy with a volume of ≤35 cc, 10 patients (9.1%) had a Gleason score of ≥8. Of the 27 patients testing positive on biopsy with a volume of ≥65 cc, only 1 patient (3.7%) had a Gleason score of ≥8. CONCLUSION: These results suggest that there may be an association between prostate volume and the incidence and aggressiveness of PCa. The larger the prostate, the lower the positive biopsy rate for PCa and the lower the Gleason score.
format Online
Article
Text
id pubmed-5087757
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50877572016-11-07 Association of prostate volume with incidence and aggressiveness of prostate cancer Al-Khalil, Shadi Ibilibor, Christine Cammack, James Thomas de Riese, Werner Res Rep Urol Original Research OBJECTIVE: The aim of this study was to investigate the possible correlation between prostate volume and aggressiveness and incidence of prostate cancer (PCa). PATIENTS AND METHODS: A chart review of a cohort of 448 consecutive prostate biopsy-naive men was performed. These men underwent at least a 12-core biopsy at our institution due to increased prostate-specific antigen serum levels (>4 ng/mL) and/or suspicious findings on digital rectal examination during the period between 2008 and 2013. Transrectal ultrasound was used to determine the prostate volume. RESULTS: The positive biopsy rate was 66% for patients with a prostate volume of ≤35 cc and 40% for patients with a prostate volume of ≥65 cc (P<0.001). Of the 110 patients testing positive on biopsy with a volume of ≤35 cc, 10 patients (9.1%) had a Gleason score of ≥8. Of the 27 patients testing positive on biopsy with a volume of ≥65 cc, only 1 patient (3.7%) had a Gleason score of ≥8. CONCLUSION: These results suggest that there may be an association between prostate volume and the incidence and aggressiveness of PCa. The larger the prostate, the lower the positive biopsy rate for PCa and the lower the Gleason score. Dove Medical Press 2016-10-26 /pmc/articles/PMC5087757/ /pubmed/27822463 http://dx.doi.org/10.2147/RRU.S117963 Text en © 2016 Al-Khalil et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Al-Khalil, Shadi
Ibilibor, Christine
Cammack, James Thomas
de Riese, Werner
Association of prostate volume with incidence and aggressiveness of prostate cancer
title Association of prostate volume with incidence and aggressiveness of prostate cancer
title_full Association of prostate volume with incidence and aggressiveness of prostate cancer
title_fullStr Association of prostate volume with incidence and aggressiveness of prostate cancer
title_full_unstemmed Association of prostate volume with incidence and aggressiveness of prostate cancer
title_short Association of prostate volume with incidence and aggressiveness of prostate cancer
title_sort association of prostate volume with incidence and aggressiveness of prostate cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087757/
https://www.ncbi.nlm.nih.gov/pubmed/27822463
http://dx.doi.org/10.2147/RRU.S117963
work_keys_str_mv AT alkhalilshadi associationofprostatevolumewithincidenceandaggressivenessofprostatecancer
AT ibiliborchristine associationofprostatevolumewithincidenceandaggressivenessofprostatecancer
AT cammackjamesthomas associationofprostatevolumewithincidenceandaggressivenessofprostatecancer
AT deriesewerner associationofprostatevolumewithincidenceandaggressivenessofprostatecancer